Q2 2020 Theravance Biopharma Inc Earnings Call Transcript
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma conference call. (Operator Instructions) Today's conference call is being recorded.
And now I would like to turn the call over to Gail Cohen, Vice President, Corporate Communications and Investor Relations. Please go ahead.
Good afternoon, everyone, and thank you for joining the Theravance Biopharma conference call and webcast to discuss our second quarter 2020 financial results and outlook.
As always, I remind you that this conference call will continue forward-looking statements, which involve certain risks and uncertainties, including statements about our product pipeline, expected benefits of our products, the anticipated timing of trial results and regulatory filings and expected sales and financial results. Information concerning factors that could cause results to differ materially from other forward-looking statements is described further in the company's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |